Drugs / MINHAI PCV13
MINHAI PCV13
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02494999 | Jun 2016 → Dec 2018 | pneumonia | Jiangsu Province Centers for Disease Control and Prevention | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MINHAI PCV13 | “A phase 3 clinical trial of MINHAI PCV13 in Chinese children aged from 7 months to 5 years old.” PMID 34706841 ↗ Oct 2021 |
| Known as | 13-valent pneumococcal conjugate vaccine | “A new 13-valent pneumococcal conjugate vaccine (PCV13) with carrier tetanus toxoid and diphtheria toxoid was developed by MINHAI, aiming to prevent pneumococcus infection.” PMID 34706841 ↗ Oct 2021 |
| Known as | PCV13 | “A new 13-valent pneumococcal conjugate vaccine (PCV13) with carrier tetanus toxoid and diphtheria toxoid was developed by MINHAI, aiming to prevent pneumococcus infection.” PMID 34706841 ↗ Oct 2021 |
| Modality | Vaccine | “A new 13-valent pneumococcal conjugate vaccine (PCV13)” PMID 34706841 ↗ Oct 2021 |
| Route | Intramuscular | “Single 0.5 ml dose will be given via intramuscular injection in Month 0,2,4 and 10” NCT02494999 ↗ |